Brand: ProteoGenix

Evinacumab Biosimilar – Anti-ANGPTL3 mAb – Research Grade

PX-TA1369
Quality Chart

Clonality:: Monoclonal Antibody
Isotype:: IgG4, Kappa

$238.00

+ 238 loyalty points

Size Size

100ug $238.00
1MG $952.00

First Name This field is required. Last Name This field is required. Email This field is required. Company This field is required. Country This field is required. State This field is required.

In Stock
Wide range of unique reagents
Fast worldwide delivery

SDS-PAGE for Evinacumab Biosimilar - Anti-ANGPTL3 mAb

Evinacumab Biosimilar - Anti-ANGPTL3 mAb - Research Grade

Product name	Evinacumab Biosimilar - Anti-ANGPTL3 mAb - Research Grade
Source	CAS 1446419-85-7
Species	Homo sapiens
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB
Aliases /Synonyms	Evinacumab,REGN 1500,ANGPTL3,anti-ANGPTL3
Reference	PX-TA1369
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG4-kappa
Clonality	Monoclonal Antibody

Product name	Evinacumab Biosimilar - Anti-ANGPTL3 mAb - Research Grade
Source	CAS 1446419-85-7
Species	Homo sapiens
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB,,,
Aliases /Synonyms	Evinacumab,REGN 1500,ANGPTL3,anti-ANGPTL3
Reference	PX-TA1369
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG4-kappa
Clonality	Monoclonal Antibody

General information on Anti-ANGPTL3[Homo sapiens] (Evinacumab) Monoclonal Antibody

Evinacumab is a recombinant human IgG4 monoclonal antibody targeting human angiopoietin-like protein 3 (ANGPTL3). The ANGPTL protein family has many physiological functions-including the regulation of lipid metabolism. It has been noted that the loss-of-function mutation of ANGPTL3 leads to hypolipidemia and subsequently reduces cardiovascular risk, while increased function seems to be related to cardiovascular risk. Evinacumab has been used to treat homozygous familial hypercholesterolemia (HoFH). It has been sold under the Evkeeza brand name.

SDS-PAGE for Evinacumab Biosimilar - Anti-ANGPTL3 mAb

Evinacumab Biosimilar - Anti-ANGPTL3 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

There are no reviews yet.

Be the first to review “Evinacumab Biosimilar – Anti-ANGPTL3 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Evinacumab Biosimilar – Anti-ANGPTL3 mAb – Research Grade

Evinacumab Biosimilar - Anti-ANGPTL3 mAb - Research Grade

General information on Anti-ANGPTL3[Homo sapiens] (Evinacumab) Monoclonal Antibody

SDS-PAGE for Evinacumab Biosimilar - Anti-ANGPTL3 mAb

Related products

Angiopoietin-related protein 3(Angptl3)

Human IgG4 Isotype Control antibody

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Evinacumab Biosimilar – Anti-ANGPTL3 mAb – Research Grade

Specifications Evinacumab Biosimilar - Anti-ANGPTL3 mAb - Research Grade

Description

General information on Anti-ANGPTL3[Homo sapiens] (Evinacumab) Monoclonal Antibody

Documents

QC & Validation

SDS-PAGE for Evinacumab Biosimilar - Anti-ANGPTL3 mAb

Reviews

Related products

Angiopoietin-related protein 3(Angptl3)

Human IgG4 Isotype Control antibody

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Evinacumab Biosimilar - Anti-ANGPTL3 mAb - Research Grade